What are the guidelines for using oral steroids, such as prednisone (corticosteroid), for treating nasal and tonsils swelling?

Oral Steroids for Nasal and Tonsil Swelling

Tonsil Swelling

For tonsillectomy in children, clinicians should administer a single intraoperative dose of intravenous dexamethasone (0.5 mg/kg, though doses as low as 0.15 mg/kg may be equally effective, with maximum dose range of 8-25 mg), which decreases postoperative nausea/vomiting, throat pain, and time to resumption of oral intake. 1

Key Points for Perioperative Tonsillectomy Management

• The mechanism of dexamethasone efficacy is likely related to anti-inflammatory properties that reduce pain and swelling 1
• Benefits include decreased incidence of postoperative nausea/vomiting up to 24 hours post-tonsillectomy, decreased times to first oral intake, and decreased pain as measured by lower pain scores 1
• This is a strong recommendation based on randomized controlled trials and systematic reviews with a preponderance of benefit over harm 1
• Exclude patients with endocrine disorders already receiving exogenous steroids or those in whom steroid administration may interfere with normal glucose-insulin regulation (e.g., diabetics) 1

Important Caveat

• Oral corticosteroids are not routinely recommended for tonsil swelling outside the perioperative setting, as the evidence base focuses on intravenous dexamethasone at the time of surgery 1

---

Nasal Swelling (Rhinitis and Rhinosinusitis)

When to Use Oral Steroids

A short course (5-7 days) of oral corticosteroids may be appropriate for very severe nasal symptoms in allergic rhinitis, but intranasal corticosteroids remain the first-line treatment and oral steroids should be reserved for exceptional cases. 1

For chronic rhinosinusitis with nasal polyps (CRSwNP), short courses of oral corticosteroids (7-21 days) combined with intranasal corticosteroids result in significant reduction in total symptom score and nasal polyp score. 1

Specific Dosing Protocols

For Chronic Rhinosinusitis with Nasal Polyps

• Prednisolone 0.5 mg/kg tapered over 10 days is effective, with 52.5% of patients avoiding surgery at 12 months 2
• Alternative regimens include oral methylprednisolone 1 mg/kg reduced progressively over 15-21 days 1, 3
• Dosages ranging from 25-60 mg prednisolone for 7-20 days have been studied 1
• Patients with symptom duration less than 11 months are most likely to benefit from oral steroids 2

Treatment Response Timeline

• At 2-3 weeks after starting oral steroids: significant improvement in symptom scores (large effect size, SMD -2.84) and nasal polyp scores (SMD -1.51) 1, 4
• At 10-12 weeks: the difference in symptom scores is no longer significant (SMD -0.13), though nasal polyp scores remain improved (SMD -0.51) 1
• The beneficial effects are maintained by subsequent administration of maintenance intranasal corticosteroids 1

Critical Limitations and Contraindications

Oral corticosteroids should NOT be administered as therapy for chronic rhinitis except for rare patients with severe intractable nasal symptoms unresponsive to other treatments. 5

Long-term or repeated parenteral corticosteroids are contraindicated due to the greater potential for long-term adverse effects. 1, 5

Adverse Effects to Monitor

• Insomnia (RR 3.63 compared to placebo) 4
• Gastrointestinal disturbances (RR 3.45 compared to placebo) 4
• Mood or behavioral disturbances (though not significantly increased at typical dosages) 4
• Side effects reported in 8.9% of prednisolone-treated patients in one study 2
• Rare but serious: avascular necrosis and fatal varicella-zoster in immunocompetent patients 1

Proper Treatment Algorithm

1. First-line: Intranasal corticosteroids are the most effective monotherapy for nasal swelling from allergic rhinitis or chronic rhinosinusitis 1, 6, 5

2. Second-line for inadequate response: Add intranasal antihistamine to intranasal corticosteroid for moderate-to-severe symptoms 6, 5

3. Reserve oral steroids for:

   • Very severe nasal symptoms in allergic rhinitis (5-7 day course) 1
   • Chronic rhinosinusitis with nasal polyps requiring rapid improvement (7-21 day course with taper) 1, 7
   • Pre-operative preparation to facilitate surgical procedure 8
   • Patients with CRSsNP with symptom duration <11 months who have failed intranasal steroids 2

4. Always follow oral steroids with maintenance intranasal corticosteroids to sustain benefits 1

Precautions from FDA Labeling

• Use the lowest possible dose to control the condition 9
• Reduce dosage gradually when possible 9
• Use with caution in patients with congestive heart failure, hypertension, renal insufficiency, peptic ulcers, or cirrhosis 9
• Drug-induced secondary adrenocortical insufficiency may persist for up to 12 months after discontinuation following large doses for prolonged periods 9

Common Pitfall to Avoid

• Do not use recurrent or long-term oral corticosteroids for chronic nasal symptoms - this leads to significant systemic adverse effects without sustained benefit, as the improvement at 2-3 weeks is not maintained at 10-12 weeks without concurrent intranasal steroid therapy 1, 5, 4